Cystic fibrosis ΔF508 heterozygotes, smoking, and reproduction: Studies of 9141 individuals from a general population sample

Genomics

Volumn 50, Issue 1, 1998, Pages 89-96

  Dahl, Morten ^a   Tybjærg Hansen, Anne ^a,b   Wittrup, Hans H ^a   Lange, Peter ^b   Nordestgaard, Børge G ^a,b,c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; AGED; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CIGARETTE SMOKING; CYSTIC FIBROSIS; EPITHELIUM CELL; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; SAMPLING;

EID: 0032524611     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1998.5272     Document Type: Article

References (31)

1. Altman D. G. Comparing groups - Continous data. Practical Statistics for Medical Research. 1991;Chapman & Hall, London. p. 179-228.
2. Appleyard M., Hansen A. T., Schnohr P., Jensen G., Nyboe J. The Copenhagen City Heart Study. A book of tables with data from the first examination (1976-78) and a five year follow-up (1981-83). Scand. J. Soc. Med. 170:1989;1-160.
3. Boyers S. P. Keye W. R., Chang R. F., Rebar R. W., Soules M. R. Infertility: Evaluation and Treatment. 1995;195-229 Saunders, Philadelphia.
4. Cassano W. F. Cystic fibrosis and the plague. Med. Hypotheses. 18:1985;51-52.
5. Chillón M., Casals T., Mercier B. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N. Engl. J. Med. 332:1995;1475-1480.
6. Conneally P. M., Merritt A. D., Yu P-L. Cystic fibrosis: Population genetics. Tex. Rep. Biol. Med. 31:1973;639-650.
7. Danks D. M., Allan J., Anderson C. M. A genetic study of fibrocystic disease of the pancreas. Ann. Hum. Genet. 28:1965;323-356.
8. Davis P. B., Drumm M., Konstan M. W. Cystic fibrosis. Am. J. Repir. Crit. Care Med. 154:1996;1229-1256.
9. De Vries H. G., Collée J. M., Meeuwsen W. P., Scheffer H., Ten Kate L. P. Number and sex of offspring of ΔF508 carriers outside cystic fibrosis families. Hum. Genet. 95:1995;575-576.
10. Gabriel S. E., Brigman K. N., Koller B. H., Boucher R. C., Stutts M. J. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science. 266:1994;107-109.
11. Hayslip C. C., Hao E., Usala S. J. The cystic fibrosis transmembrane regulator gene is expressed in the human endocervix throughout the menstrual cycle. Fertil. Steril. 67:1997;636-640.
12. Hollander D. H. Etiogenesis of the European cystic fibrosis polymorphism: Heterozygote advantage against venereal syphilis. Med. Hypotheses. 8:1982;191-197.
13. Jorde L. B., Lathrop G. M. A test of the heterozygote-advantage hypothesis in cystic fibrosis carriers. Am. J. Hum. Genet. 42:1988;808-815.
14. Khoury M., Beaty T., Cohen B. Fundamentals of Genetic Epidemiology. 1993;Oxford Univ. Press, New York. p. 107-108.
15. Knudson A. G., Wayne L., Hallet W. Y. On the selective advantage of cystic fibrosis heterozygotes. Am. J. Hum. Genet. 19:1967;388-392.
16. Meindl R. S. Hypothesis: A selective advantage for cystic fibrosis heterozygotes. Am. J. Phys. Anthropol. 74:1987;39-45.
17. Norušis, M. J. 1993a, SPSS for Windows. Base System User's Guide, SPSS Inc. Chicago, IL.
18. Norušis, M. J. 1993b, SPSS for Windows. Advanced Statistics, SPSS Inc. Chicago, IL.
19. Poulsen J. H., Fischer H., Illek B., Machen T. E. Bicarbonate conductance and pH regulatory capability of cystic fibrosis transmembrane conductance regulator. Proc. Natl. Acad. Sci. USA. 91:1994;5340-5344.
20. Rotter J. I., Diamond J. M. What maintains the frequencies of human genetic diseases. Nature. 329:1987;289-290.
21. Schwartz M., Brandt N. J., Koch C., Lanng S., Schiøtz P. O. Genetic analysis of cystic fibrosis in Denmark. Implications for genetic counselling, carrier diagnosis and prenatal diagnosis. Acta Paediatr. 81:1992;522-526.
22. Shier W. T. Increased resistance to influenza as a possible source of heterozygote advantage in cystic fibrosis. Med. Hypotheses. 5:1979;661-668.
23. Snedecor G. W., Cochran W. G. Statistical Methods. 1980;Iowa State Univ. Press, Ames. p. 360-361.
24. Strickler, R. C. 1995, Infertility: Evaluation and Treatment, W. R. KeyeR. F. ChangR. W. RebarM. R. Soules, 8, 18, Saunders, Philadelphia.
25. Stuart A.B., Burdon M.G. Frequency of cystic-fibrosis gene. Lancet. 2:1974.
26. Talmud P., Tybjærg-Hansen A., Bathnagar D. et al. Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia. Atherosclerosis. 89:1991;137-141.
27. Tizzano E. F., Silver M. M., Chitayat D., Benichou J-C., Buchwald M. Differential cellular expression of cystic fibrosis transmembrane regulator in human reproductive tissues. Clues for the infertility in patients with cystic fibrosis. Am. J. Pathol. 144:1994;906-914.
28. Vine M. F., Tse C.-K. J., Hu P. C., Truong K. Y. Cigarette smoking and semen quality. Fertil. Steril. 65:1996;835-842.
29. Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ. Res. 47:1980;1-9.
30. Welsh M. J. Cigarette smoke inhibition of ion transport in canine tracheal epithelium. J. Clin. Invest. 71:1983;1614-1623.
31. Welsh M. J., Tsui L-C., Boat T. F., Beaudet A. L. Scriver C. R., Beaudet A. L., Sly W. S., Valle D. The Metabolic and Molecular Bases of Inherited Disease. 1995;3799-3876 McGraw-Hill, New York.